当前位置: 首页 > 期刊 > 《医学信息》 > 2009年第6期
编号:11881322
国产利培酮治疗精神分裂症的疗效、安全性及经济性研究
http://www.100md.com 2009年6月1日 《医学信息·下旬刊》 2009年第6期
国产利培酮治疗精神分裂症的疗效、安全性及经济性研究

     【摘要】目的:探讨国产利培酮在治疗精神分裂症的疗效、安全性及经济性。方法:对120例门诊或住院精神分裂症患者使用国产利培酮治疗6周,分别于治疗前后进行阳性和阴性症状量表(PANSS)测查。结果:治疗第一周末,PANSS总分及分量表分与基线比较,即有明显降低(P=0.000),PANSS总减分率为1 3.2%。治疗第6周末,PANSS总分减分率达68.1%,治疗有效率76.5%,发生不良反应61次,主要不良反应:静坐不能、震颤、肌张力障碍等,且程度轻微。每粒国产利培酮较进口利培酮少1.45元。结论:国产利培酮治疗精神分裂症有效安全、经济。

    【关键词】国产利培酮;精神分裂症;有效性;安全性;经济性

    Risperidone in the treatment of schizophrenia made of the efficacy, safety and economic studies

    ZHANGHua

    【Abstract】 Objective: To explore the domestic risperidone in the treatment of schizophrenia, safety and economy. Methods: 120 cases of schizophrenia patient or out-patient use of risperidone in the treatment of Chinese-made 6 weeks before and after treatment were carried out in positive and negative symptom scale (PANSS) Test. Results: The treatment of the first weekend, PANSS total scores and sub-sub-scales compared with the baseline, that is significantly lower (P = 0.000), PANSS total reduction rate of 1 to 3.2%. Treatment No. 6 over the weekend, PANSS total score reduction rate of 68.1 percent, 76.5 percent efficiency of treatment, 61 adverse reactions occurred, the main side effects: akathisia, tremor, dystonia, etc.And minor. Each Chinese-made imports Risperidone Risperidone less than 1.45 yuan. Conclusion: Risperidone treatment of schizophrenia made effective security, economic. ......

您现在查看是摘要页,全文长 4517 字符